BioVoice News December 2016-January 2017 Issue 8 Volume 1 - Page 26

bio event

projected target for pharma is close to $ 300 billion and for biotech , it is $ 100 billion . Therefore , the combined target by 2025 is $ 400 billion . I see India as a leader . We are currently around $ 35 billion , we need to get to $ 100 billion soon and this would propel manufacturing and employment . People forget that by doing this , a huge social infrastructure will also develop around it , which is good for the country and its general economy ."
“ Typically small organizations do research and get sold off to big MNCs after they achieve some success . I feel this model will be broken shortly . We have to bear in mind the need for healthy regulation . Between intent and delivery of technology , public attitude has determined the implementation of the technology . Each type of innovation can have incremental , disruptive or destructive effect .

Presence of lot of undiagnosed people is a major issue that requires attention . So the challenge is to identify such population and prevent NCDs . To diagnose , we require more equipment in public health sector .
Evidence based technology should not fall prey to the fear mongering . The reaction should be based on logic not emotional responses . We are looking forward to work with the NITI Aayog to together work towards a stronger Indian bioeconomy by 2025 ,” added Mr Murali ."
Talking about the major objective behind the event , Dr Kiran Mazumdar-Shaw , Honorary Non Executive Chairman of ABLE , and CMD at Biocon mentioned , " The conclave aims to create a nationwide awareness of the economic potential of Biotechnology across various sectors viz Healthcare , Agriculture , Energy and Sustainable solutions for Industry . It also aims to bring policy makers , the Departments of Biotechnology , the ministries of Health , Food & Agriculture , Environment , the Department of Industrial Policy & Promotion ( DIPP ), and NITI Aayog onto a common platform ."
Mr G S Krishnan , Regional President , Novozymes , India in his comments told BioVoice News , ” BioEconomy Conclave event has been held at the right time , especially when there is lot of attention for sustainable solutions from the government . In the industrial biotech segment we covered , food , textile , detergent and bionergy . We see a big opportunity for growth .”
26
BioVoiceNews | December 2016 - January 2017